COMPANY REGISTRATION NUMBER: 01983718
CHARITY REGISTRATION NUMBER: 293754
The College of Clinical Perfusion Scientists of Great
Britain and Ireland
Company Limited by Guarantee
Unaudited financial statements
30 November 2023

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Financial statements
Year ended 30 November 2023
Page
Trustees, annual report lincorporaling the directors, report)
Independent examiner's report lo the Iruslees
10
Stslemenl of financial activities (including income and expenditure accountl
11
Balance sheet
12
Notes lo the financial statements
13

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Trustees, annual report (incorporating the directors. report)
Year ended 30 November 2023
The trustees, who are also the directors for the purposes of company law, present their report and the
unaudited financial slalements of the charity for the year ended 30 November 2023.
The financial slalemenls have been p￿pared in accordance with the accounting policies sel out in notes lo
the accounts and comply wth the charity's govèrning document, the Charities Act 2011 and Companies Act
2006 and Accounting and Reporting by Charities". Statement of Recommended Practice applicable lo
charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK
and Republic of Ireland published in October 2019.
Reference and administrative details
Registered charity name
The College of Clinical Perfusion Scientists of Great Britain and Ireland
Charity registration number
293754
Company reglstratlon number
01983718
Prlnclpal offlce and reglstered Royal College of Surgeons of England
offl¢e
College of Clinical Perfusion Scientists
Fifth Floor
Lincoln's Inn Fields
London
WC2A 3PE
The trustees
The trustees who served during the year and al the date of approval were as follows..
A Ahmed
A Brennan (Treasurer)
D Chambers (resigned 2 November 20231
C Efthymiou
(resigned 2 November 20231
A Meakin Iresigned 2 November 20231
B Pates
J O'Neill (appointed Secretary 18 January 20231
P Fricker (resigned as Secretary 18 January 20223, appointed as Chair
18 January 20231
J Tyrrell
M Chaudhry (deceased 15 June 20231
B Pale
A Murton
C Boynton
B Evans (Appointed 29 April 20241
A Beatson (Appointed 2 November 20231
F Holmes lappointed 2 November 20231
G Lucchese lappoinled 2 November 20231

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Trustees, annual report (incorporating the directors. report) (¢ortlinued)
Year ended 30 November 2023
Independent examlner
Mark Proctor FCA DChA
Lovewell Blake LLP
Chartered accountsnts
Bankside 300
Peachman Way
Broadland Business Park
Norwch
NR7 OLB
Bankers
Barclays Bank PLC
Barclays Banking
Leicester
LE87 28B

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Trustees, annual report (incorporating the directors. report) (¢ortlinued)
Year ended 30 November 2023
Oblectlves and actlvltl&s
Profgsslonal rggl$tratlon and rggulatlon of Cllnl¢al Perfuslon S¢lentl$ts In Groat Brltsln and Ireland
The College is the professional governing body of Clinical Perfusion Scientists in Great Britsin and Ireland
and holds the register of all Clinical Perfusion Scientists that are eligible lo practice within Great Britain and
Ireland. The College works lo ensure that all registered Clinical Perfusion Scientists are fil lo practice. This
is defined through an ability to uphold the standards and Codes of practice as defined by the Society of
Clinical Perfusion S¢ientisls of Great Britain and Ireland ISCPSGBII and by working in a¢cordan¢e with the
code of ethical condu¢l la joint document by the College and SCPSGBII. The College ensures that all
individuals maintain competency by completing a minimum amount of clinical work whilst maintaining
continuing professional development through education.
The College will investigate and discipline individuals whose conduct falls short of the required standards.
At this b'me the profession has not achieved statutory regulation and as a result, the College undertakes the
regulation of Clinical Perfusion Scientists. This includes conducting disciplinary hearings and the striking off
from the register of any Clinical Perfusion Scientist as required. The College musl ensure all praclicing
Clinical Perfusion Scientists within the Great Britain and Ireland are competent lo practice and ensure that
patient safely is paramount. The College will seek legal advice when ￿e￿ssary and on occasions instruct a
law firm lo act on the College's behalf. The continued lack of slatulory professional regulation of Clinical
Perfusion Scientists brings with Il the challenges of obtaining access to required information, which other
governing bodies would automatically access.
In complex disciplinary cases, the College Council estsblishes a profession practice committee IPPCI to
investigate, review evidence of alleged misconduct and detemiine what, if any, disciplinary action is
deemed appropriate. The PPC will seek legal advice to ensure that il follows policy and law and responds
accordingly lo individual's legal advisors. There are governance costs which may include the cost of
obtsining Counsel's advice in specific points of law andlor procedure.
Accreditation of Perfusion Departments to ensure stsndards in practice and training
The College undertakes assessment of perfusion practice in cardiac centres with resultant accreditation if
appropriate standards of practice and training are evident. The College highlights any areas of concerns
raised as a result of a site assessment and details an action log of criteria to be brought up to standard
before full accreditation is granted. Accreditation is reassessed every 5 years. Perfusion departments can
also request urgent College visits if there is concem regarding safe practice and patient care.
Tralnlng and Educatlon
The College will liaise with and consult with the Society of Clinical Perfusion Scientists of Great Britain and
Ireland, lo advance education In the knowledge and practice of perfusion and related studies for the benefit
of the public. A recurring contribution from the College lo the Society will aid in the advancement of
Pèrfusion education. This includès liaising and consulting with other professional bodies and inslilulions
deemed necessary in pursuing these objectives.
Derivation of Funds
The College's funds are derived from revenue generated from both NHS and private health sedor for
hospital sile accreditation certification and from the annual re-registration fees from all Clinical Perfusion
Scientists on the professional register. A small additional amount of income is also derived from course
validation fees and late payment fees.

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Trustees, annual report (incorporating the directors. report) (¢ortlinued)
Year ended 30 November 2023
Oblectlves and actlvltles (continued)
Publlc Beneflt
The Trustees have Considered the Charity Commission's requirement in ￿SpeCt of Public Benefit," in their
view the Charity meets, in full, the criteria to satisfy the lesl.

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Trustees, annual report (incorporating the directors. report) (¢ortlinued)
Year ended 30 November 2023
Achlevements and performance
The college of Clinical Perfusion Scientists of Great Britain and Ireland hold the following membership
registration details as of November 2023".
471 Clinic41 Perfusion Scientists with full registration
5 Clinical Perfusion Clinical Perfusion Scientists on extended leave
63 trainee Clinical Perfusion Scientists
13 limited registration Perfusion Scientists
The College has continued the programme of assessing Clinical Perfusion Scients'sls and Perfusion ￿ntre$
in order to maintain the accepted professional standards required and to provide on-going clinical perfusion
guidance. The College undertook 6 category one hospital site accreditation visits to perfusion departments
in the UK and Ireland be￿een 1st December 2022 to 30th November 2023. These have returned to in-
person visits post-COVID restrictions. The Unit Accreditalion visit timetable is still heavily impacted by the
COVID pandemic and a considerable backlog of visits needing to be performed for departments that have
now surpassed the S-year reaccreditalion timeframe exists. With previous years. visits there had been
issues in appropriately timed payment for Some of the visits, requiring multiple reminders and request for
payments being sent. However, for this financial period the majority of payments were made in a timely
manner wth the ex￿ption of one hospital. It was discussed during the College Council meetings and the
Council members tasked lo find solutions In resolving these issues. The idea of late payment fees was
suggested lo encourage timely payment.
There were 8 unit accreditation visits undertaken between November 2022 and December 2023, they are
Iisled below".
The Cleveland Clinic London - visit look place 6th December 2022, payment received 3rd February 2023
Blackrock Health Galway Clinic- visit look place 7th March 2023, payment received 11th April 2023
King's College Hospitsl, London- visit look pla￿ 20th April 2023, payment received 19th May 2023
Spire Healthcare, Southampton - visit took place 21 st April 2023, payment received 20th July 2023
Liverpool Heart and Chest Hospital - visit took place 17th May 2023, payment re￿iVed 24th January
2024
st George's Hospital, London - visit look place 25th May 2023, Payment received 11th July 2023
Northern General Hospitsl, Sheffield
January 2024
visit took place 18th September 2023, payrnenl ￿ceiVed 29th
Alder Hey Hospitsl, Liverpool - visit look place 14th November 2023, payment received 6th March 2024
As can be seen from the payment dales, some of the fees were paid after the financial period end of 2022-
2023.
The perfusion Community is kept informed of all the College's income and expenditure regularly al the
Annual General meeting each year and the College Council meet 415 limes per year where a Treasurer
update is provided each meeting.

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Trustees, annual report (incorporating the directors. report) (¢ortlinued)
Year ended 30 November 2023
Achlevements and performance {conlinued)
ststementof Impa￿ on the Charlty ofCovld-19
With the retum lo in-person unil accredilalion visits, and a now hybrid system of in-person and virtual
College Council meetings the impact from COVID-19 on the College finances has now abated. Financially
the College still receives income from the re-registralion of all clinical perfusionisls. As a result of the virtual
aspect of the unit accredilalion visits during the pandemic there were no expenses accrued by the
assessors and therefore the price of the visit was red￿￿d to account for this down lo £2,000 fee. Once the
assessors began lo attend in person again. the fee reverted back lo £2,500 in early 2022. However. there
has been a consideration increase in the cost-of-living post pandemic that saw the unil assessorfs expense
claim increase quite significanuy. After discussion al the College Council meetings the decision was made
lo increase the visit fee to the hospital to £3.000 to offset the increase in expense claims. There is still a
considerable backlog of visits to be performed post Covid-19 which has put the planned visit timetable back
possibly years with many departments now overdue. It is expected that until the visit cycle can fully return to
normal the financial status of the College should be monitored carefully. The aim of the College Council is
lo perform 1 (kunit accreditation visits per year creating a revenue of £30,000. Unfortunately, the role of
College Assessor for these visits is a voluntary position and it has proven difficult in securing the necessary
number of of assessors required to fulfil the target number of visits this year. The College Council have
made the decision to hold a workshop lo encourage new assessors lo come on board and that an increase
in assessor numbers would enable the shortfall lo be addressed next period.

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Trustees, annual report (incorporating the directors. report) (¢ortlinued)
Year ended 30 November 2023
Flnanclal revlew
The college had total Income for the year of £68,518 12022". £55,848), and expenditure of £54,971 12022..
£62,768) resulting In nel Income of £13,54712022". nel expenditure of £6,920).
The College, position has thankfully improved from the previous financial period in 2022 and a significant
net expenditure. The return lo in-person unil accredilalion visits has helped lo slabilise the College's
income. this is a result of a significant number of visits undertaken and the increase in the fees lo
compensated for the assessorfs expenses. Also, the final payment of the inleresl-free loan from the Society
of Clinical Perfusion Scientists in June 2022 has meant that the College's saves £5,000 per year. The
College is able to hold the agreed upon Reserve level and the balance is looking healthy.
The primary source of income for the College is the annual re-registration fee from each registrant. The
registration fee for 2023 was £90. Some additional charges from lale fees incurred after failure for members
lo pay within the designated timeframe are included. Income from regislration for this period was £44,800.
The second source of income is generally derived from perfusion department accreditation visits. This was
£22,530 this period. Of the 8 visit that took place, 3 of these fell within the old fee of £2,500. The other 5
visits were charged at £3,000 and one unil was invoiced for incurred expenses for cancelling a visit last
minute.
There was a small amount of income generated from limited registration exams. However, with he moved of
the registration pathway for oversea and limited registrants changing to Bristol University the College will no
longer receive income from this pathway in future. There is occasional small income generated from course
validation fees, but none were submitted in this period.
A new business account has been established between the College and Society wth Premier Inn hotels.
This has allowed for discounted rates for rooms for assessors when Iravelling lo attend Unil Accreditslion
visits and helps to streamline the costs of expenses for these visits. Where possible assessors are
encouraged to make use of this service and can be booked diredy with the College's administrator. This
will hopefully minimise the cost of hotel stays on these visits.
The review of the College's policies and prO￿d￿re$ documentation ¢ame about due lo an increase in
requests for the College to investigate potenb'al disciplinary and fitness to practice matters. 11 is expected
that there will be an increase in seeking out legal advice and proper guidan￿ in these rnatters. The
subsequent cost of the additional support has been deemed ne￿SSary to protect both the College and
membership from potential future legal costs.
Reserves policy
As of 30 November 2023, the charity had unrestricted free reserves (represented by unrestricted current
assets less unreslricled current liabilities) of £70,30612022.. £56,759).
The Ttuslees approved 8 policy of holding reserves of £45,000 In 2022 and the same reserve was agreed
for 2023. This has been held comfortably in this financial period. Reserves are defined as the amount of
unrestrided funds available lo the Iruslees for use in the objects of the charity.

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Trustees, annual report (incorporating the directors. report) (¢ortlinued)
Year ended 30 November 2023
Plans for future perlods
There is no stalulory regulation of the Clinical Perfusion Scientist profession by the government. The
society remains focused on the possibility of slatulory regulation, under the temis that will best serve not
only our mèmbership bul also our patient group. The College has agreed with the Society Executive that the
funds contributed to Society Education fund can also be used in the pursuit of slalulory regulation. The
College will continue to hold the register for the profession until slatulory regulation is attained.
The previous financial period 12021-20221 the Society of Clinical Perfusion Scientists asked the College lo
make a contribution towards the education fund that is in place for the membership. This falls under point
the College's constitution point 3.6 To fund scholarships and exhibitions and to make grants, and to
give prizes, and to give and participate in any arrangements made with any university or institute of
higher education or any other body having the appropriate powers whereby students or fo mier
students of the College may become qualified to receive any degrees or other academic
qualifications provided that no certificate. diploma or other award shall contain any statement
expressing or 5 implying that it is granted by or under the authority of the Department of Trade or
any Government Department except to such extent as may be authorised by the Department of
Trade or the department concerned.
11 was determined that the best way forward would be to contribute to the Society who are responsible for
the Education and Training of the membership. The fund would be used towards lo the cost of education
conlenl such as the Spring seminar, the cost of estsblishing a medicine management course and any other
education related courses or seminars that would take place that have been or will be organised by the
Society. This was initially intended lo be an annual contribution which will be reviewed lo lo assess the
amount depending on cost from previous year5. A contribution of £10,000 was made In the financial period
2021-2022. No further contribution has been made as the Society has indicated that the initial fund Is not
yet depleted, and they will not seek further contribution until this is the case, but the College is prepared lo
make another contribution when requèsted and supports the Society in the quest for slatulory regulation.
Structure* governance and management
The organisalion is a charitsble company limited by guarantee, incorporated on 29 January 1986 and
registered as a charity on 18 February 1986. The Company was established under a Memorandum of
Association that established the objects and powers of the charitable company and is govemed under ils
Articles of Association.
Trustees
The trustees who served during the year and up to the dale of this report as listed on page 1.
The trustees are the Council of Management of The College of Clinical Perfusion Scientis15 of Great Britain
and Ireland and are made up as follows..
Up lo 8 nominated by the Society of Clinical Perfusionist Scientists of Great Britsin and Ireland.
The Registrar of the Society of Clinical Pèrfusion Scientists of Grèat Britain and Ireland.
Two surgeons nominated by the Society of Cardiolhoracic Surgery ISCTSI.
Two anaeslhelists nominated by the Association of Cardiothoracic Anaeslhelists IACTAI.
An Academic Clinician co-opted by the council as advisor for education.

The College of Clinlcal Perfusion Scientists of Great Britain and
Ireland
Company Llmlted by Guarantee
Trustees, annual report (Incorporatlng the dlrectors. report) l¢onllnu•trJ
Year ended 30 Novembér 2023
Sm411 eompany pro¥l¥lon•
Th18 report has boen prep8red taking 8(fvantage ol the small comp•nles' aXeMp￿0￿ ol section 415A of U
Companies A¢t 2006.
The trustees, annual rep)rt was approved c
tnJ3tees by..
and signed on behaw of the iM)wd ol
A Brennan (Tre8surerl
Tru8¢ee

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Independent examiner's report to the trustees of The College of Clinical
Perfusion Scientists of Great Britain and Ireland
Year ended 30 November 2023
I report lo the charity trustees on my examination of the financial ststemenls of the company for the year
ended 30 November 2023 which comprise the slalement of financial activities (including income and
expenditure account), balance sheet and the related notes.
Responsibilit19s and basls of report
As the charity trustees of the company land also its directors for the purposes of company lawl you are
responsible for the preparation of the financial slalemenls in accordance with the requirements of the
Companies Act 2006 Ilhe 2006 Act'l.
Having satisfied myself that the financial statements of the company are not required to be audited under
Part 16 of the 2006 Act and are eligible for independent examination. I report in respect of my examination
of your company's financial statements as carried out under section 145 of the Charities Act 2011 I'the
2011 Act'l. In carrying out my examination I have followed the Directions given by the Charity Commission
under section 14515llbl of the 2011 Act.
Independent examinerfs statement
I have completed my examination. I confirm that no matters have come lo my attention in connection with
the examination giving me cause lo believe that in any material respect..
accounting records were not kept in ￿SpeCt of the company as ￿qUired by section 386 of the
2006 Act, or
the financial slalements do not accord with those records., or
the financial slalements do not comply with the accounting requirements of section 396 of the
2006 Act other than any requirement that the ac¢ounls give a 'lrue and fair, view which is not a
matter considered as part of an independent examination., or
the financial statements have not been prepared in accordance with the methods and principles
of the Statement of Recommended Practice for accounting and reporting by charities applicable
to charities preparing their accounts in accordan￿ with the Financial Reporting Standard
applicable in the UK and Republic of Ireland IFRS 1021.
I have no COn￿mS and have come across no other matters in connection with the examination to which
atL¥I ILlui i >1 IV￿ld be drawn in this report in order to enable a proper understanding of the accounts lo be
reached.
Mark Proctor FCA DChA
Independent Examiner
Lovewell Blake LLP
Chartered accounlanls
Bankside 300
Peachman Way
Broadland Business Park
Norwich
NR7 OLB
2310812024
10-

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Statement of financial activities
(including income and expenditure account)
Year ended 30 November 2023
2023
Unrestricted
funds Total funds
2022
Total funds
Note
Income and endowmgnts
Charitsblè activities
Investment income
Other income
67,680
48
790
67,680
48
790
55,185
659
Total income
68,518
6e,518
55,848
Expenditure
Charitsble activities
154.9711
154.9711
154,9711
154,9711
{62,7681
{62,7681
Total expenditure
Net incomellexpenditurel and net rnovement in funds
13,547
13,547
16,9201
Reconclllatlon of funds
Total funds brought forward
Total funds carrfed fonvard
56,759
56,759
63,679
70,306
70,306
56,759
The stslemenl of financial activities includes all gains and losses recognised in the year.
All income and expenditure derive from continuing activities.
The notes on pages 13 to 17 form part of these financial statements.
11

The College of Cllnical Perfuslon Sclentlsts of Great Brltaln and
Ireland
Company Llmltad by Guarante•
Balance 8heet
30 November 2023
2013
2022
Cufr•nt a¥s•t•
DebtOTS
CAsh At bAnk And in hAvA
12
8,500
8a.?18
80.670
92.718
80,610
Cr•dltorn: Amounts lalllng du• wlthln
on• y•ar
Nel ¢uwront as1•ts
13
22,4121
123.9111
70.306
56.759
56.759
Tvlal 455Bl• IB•• cuThent Ilablllllei
70.306
Funds ot th• charlty
Unrestricled funds
70.306
70.306
56.7S9
TOW charlty lund
14
56,759
FrA the year ending 30 Novernber 2023 Ihe chanty was enbtled to exempbon from auoii unaer sectson 477
of the Companies Acl 2006 relth.ng lo Small ¢ompanles.
Directm. TeskbJnsibilibes.'
The members ha¥e fiol feqUif8d ihe company lo c*Jiain an audit of its finanual StateM￿ts forlhe ye?r
in guestim in accordan￿ 5gclian 476..
The direclots aGknowledge th¢ir Teswsibilit1¢5 for GotnPl￿ng ￿1th Ihe requirernents of Ihe Ad
respect to a¢￿untIng recryds and Ihe preparats￿ ol fin8nrial ststements.
These hnanu81 SWtsments have been prepared In ￿Er￿rdanCe wrth Ihe p￿￿s1OnS apr4ic4bie ￿ ojmpanies
subject io Ihe small companies. regirne.
These financial ststements were appToved by Ihe board ol truste85 and aulh￿iSed issue on
.th.-.8.-..a.V.., and arg signed on behalf of the b)Jd by..
A Brenn8n (Trèasurerl
Truslee
Company registra￿￿ rwrrthr. 01983718
Th• not•• p•ges 13 to 17 form part of th•s• fl￿n¢t41 •tstsrn•n
.12.

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Notes to the financial statements
Year ended 30 November 2023
General Infomiatlon
The charity is a public benefit entity and a private company limitely by guarantee, Tegistered in
England and Wales and a registered charity in England and Wales. The address of the registered
office Is Royal College of Surgeons of England, College of Clinical Perfusion Scientists, Fifth Floor,
Lincoln's Inn Fields, London, WC2A 3PE.
statement of compliance
The charity Constitutes a public benefit entity as defined by FRS 102. The financial slalements have
been prepared in accordance with Accounting and Reporting by Charities. Statement of
Recommended Practice applicable to Charities preparing their accounts in accordance with the
Financial Reporting Standard applicable in the UK and Republic of Ireland issued in October 2019, the
Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland IFRS 1021,
the Charities Act 2011, the Companies Act 2008 and UK Generally Accepted Accounting Practice.
Accountlng pollcles
Basls of preparatlon
The financial slalements have been prepared on the historical cost basis.
The financial slalements are prepared in sterling, which is the functional currency of the entity.
Going concern
The financial statements have been prepared on a going concern basis as the Iruslees believe that no
material uncertainties exist. The trustees have Considered the level of funds held and the expected
level of income and expenditure for 12 months from aLJthorising these financial statements. The
budgeted income and expenditure is sufficient with the level of reserves for the charity to be able to
continue as a going concern.
Income
All income is Included in the statement of financial activities when enlitlemenl has passed to the
charity, il is probable that the economic benefits associated with the transaction will flow lo the charity
and the amount can be reliably measured. The following specific policies are applied lo particular
categories of income".
registration, ac¢redilalion and exam fees are recognised on an a¢cru81 basis in the Slatèmenl
of Financial Activities in the year they are receivable, which is when the charity becomes
entitled lo resource.
investment income is accounted for on a receivable basis gross of any income lax recoverable.
income from contracts for the supply of servi￿$ is re¢ognised with the delivery of the
contracted servi￿. This is Classified as unrestricted funds unless there is a contractual
requirement for it to be spent on a particular purpose and returned if unspent. in which case it
may be regarded as restricted.
13-

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Notes to the financial statements (¢¢)nfynuedJ
Year ended 30 November 2023
Accountlng pollcles (continued)
Expendlture
Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any
VAT which cannot be fully recovered, and is classified under headings of the statement of financial
activities to which it relates..
expenditure on charitable activities includes all costs incurred by a charity in undertaking activities
that further its charitable aims for the benefit of its benefi¢iaries, including those support costs and
costs relating lo the governance of the ¢harily apportioned lo charitable aclivilies.
All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs
attributable to a single activity are allocated direclly to that activity. Shared costs are apwrtioned
be￿een the activities they contribute to on a reasonable, justifiable and consistent basis.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party lo the
contractual provisions of the inslrumenl.
Basic financial instruments are initially recognised al the amount ￿Ceivable or payable including any
related transaction costs, unless the arrangement ¢onslitules a financing transaction, where it is
recognised at thè present value of the future payments discounted at a market rate of interest for a
similar debt instrument.
Current assets and current liabilities are subsequenuy measured at the cash or other consideration
expected lo be paid or received and not discounted.
Debt instruments are subsequently measured at amortised cost.
Limited by guarantee
The College has no share capital and the liability of the members is limited by guarantee to £1 each.
Charltsble actlvltles
Unrestricted Total Funds Unrestricted Total Funds
Fund5
2023
Fund5
2022
Registration fees
Accreditation visits
Exam fees
44,800
22,530
350
44,800
22,530
350
44,475
10,000
710
44,475
10,000
710
67,680
67,680
55,185
55,185
Investment income
Unrestricted Total Funds Unrestricted Total Funds
Funds
2023
Funds
2022
Bank interest receivable
48
48
14-

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Notes to the financial statements (¢¢)nfynuedJ
Year ended 30 November 2023
Other Income
Unrestrictely Total Funds Unrestricted Total Funds
Funds
2023
Funds
2022
Other income
790
790
659
659
Expenditure on charitable activities
Unrestricted Total Funds Unrestricted Total Funds
Funds
2023
Funds
2022
Travelling
General administration costs
Insurance
AGM expenses
Sundry expenses
World paylfasl pay
Conference registration fees
College Research Award
Contribution lo Society Education Fund
Governance costs
9,884
33,536
1,014
7,255
9,884
33,536
1,014
7,255
66
249
407
6,672
35,458
1,235
5,935
180
290
100
528
10,000
2,370
62,768
6,672
35,458
1,235
5,935
180
290
100
528
10,000
2,370
62,768
249
407
2,560
2,560
54,971
54,971
Anatysis of governance costs
Unrestri¢led Total Funds Unreslri¢led Total Funds
Funds
2023
Funds
2022
Independent examination
2,560
2,560
2,370
2,370
Net Incomellexpendlturel
Net incomellexpenditurel is slated after chargingllcredilingl".
2023
2022
Independent examiners fee
2,560
2,370
10. Staff costs
There were no Staff costs incurred during the year.
The average head count of employees during the year was Nil12022.' Nil}
No employee received employee benefits of more than £60,000 during the year12022.' Nil)
15-

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Notes to the financial statements (¢¢)nfynuedJ
Year ended 30 November 2023
11. Trustee remuneratlon and expenses
None of the trustees lor any persons connected wth theml received any remuneration during the
year. Eleven Ituslees were due or reimbursed In the year expenses of £6,62512022". Twelve ttuslees,
£4,703).
At the year-end there were no amounts owed lo any of the trustees 12022.. £370 owed to three
trusleesl.
12. Debtors
2023
2022
Trade debtors
8,500
13. Credltors.. Amounts falllng due wlthln one year
2023
2022
Accruals
22,412
23,911
14. Analysls of charltable funds
Unrestrlcted funds
2022
A11
December
2022
At30
November
2023
Income
Expenditure
General funds
56,759
68,518
154,9711
70,306
2021
At1
December
2021
At30
November
2022
Income
Expenditure
General funds
63,679
55,848
162,7681
56,759
16-

The College of Clinical Perfusion Scientists of Great Britain and
Ireland
Company Limited by Guarantee
Notes to the financial statements (¢¢)nfynuedJ
Year ended 30 November 2023
15. Analysls of net assets between funds
Unrestricted Total Funds
Funds
2023
Current assets
Creditors less than 1 year
Net assats
92,718
122,4121
70,306
92,718
122,4121
70,306
Unrestricted Totsl Funds
Funds
2022
Current assets
Creditors less than 1 year
Net assets
80,670
123,9111
80,670
123,9111
56,759
56,759
16. R&lated partles
There were no related party transactions in the current or previous year other than those detailed in
note11.
17-